1-855-843-4782 | Fax 1-844-611-8975 info@drsalesdirect.com

MONOVISC® INJECTION, 4ML

$349.00

Monovisc injection is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy or simple analgesics (e.g., acetaminophen).

Manufacturer: Anika Therapeutics
Strength: 22mg/ml
Pack Size: 1 X 4ml Pre-Filled Syringe

Quantity Discount (%) Price
1 - 5 $349.00
6 - 10 2.87 % $339.00
11 - 20 4.3 % $334.00
21+ 5.73 % $329.00
SKU: MONOVISC? 4 ml 20mg/ml Category:

Additional information

Monovisc is an advanced hyaluronic acid injection specifically formulated to treat osteoarthritis pain and improve joint function. Composed of ultra-pure, high molecular weight sodium hyaluronate, Monovisc mimics the natural synovial fluid found in healthy joints. This single-injection treatment provides effective lubrication and cushioning, reducing pain and improving mobility for osteoarthritis patients.

Monovisc’s non-animal-derived composition ensures it is well-tolerated by most patients, minimizing the risk of allergic reactions. The unique formulation helps restore the natural viscoelastic properties of synovial fluid, enhancing joint lubrication and shock absorption, thereby improving overall joint health and reducing discomfort.

Indication and Applications:

Monovisc is indicated for the treatment of pain in osteoarthritis of the knee in patients who have not responded adequately to conservative non-pharmacologic therapy or simple analgesics like acetaminophen.

Main Treatment Areas:

  • Knee Joint: Provides significant pain relief and improves mobility, reducing stiffness and discomfort.

Monovisc Injection Key Benefits:

  • Single-injection convenience
  • Long-lasting pain relief
  • High molecular weight for effective cushioning

Ingredients:

  • Sodium Hyaluronate: A naturally occurring substance that provides lubrication and cushioning to the joints. Monovisc’s hyaluronic acid is highly purified and non-animal-derived.

Purchase Information

Monovisc injection is available in pre-filled 4mL syringes designed for single-use injections, providing convenience and sterility for treating osteoarthritis knee pain. This product is intended for professional use and can be purchased from reputable medical suppliers. For wholesale pricing and bulk order discounts, Monovisc can be obtained through Dr Sales Direct, ensuring product authenticity and quality. Clinics and healthcare providers benefit from competitive pricing when ordering in larger quantities.

Frequently Asked Questions

Monovisc injections can provide effective pain relief for knee osteoarthritis for up to six months. The duration may vary depending on individual patient factors.

Monovisc is used to treat knee pain caused by osteoarthritis. It acts as a lubricant and shock absorber in the knee joint, helping to restore the viscoelastic properties of the synovial fluid and improve joint function.

Monovisc contains a high molecular weight, ultra-pure form of hyaluronic acid derived from bacterial cells. It is a viscosupplement designed to mimic the natural hyaluronic acid found in healthy joints.

After a Monovisc injection, patients may experience pain relief starting within two weeks, with effects lasting up to six months. There may be temporary pain or swelling at the injection site, which should subside within a few days.

Monovisc is effective in reducing pain and improving joint function in patients with knee osteoarthritis. Clinical studies have shown significant improvements in pain scores and joint mobility for many patients.

Monovisc is typically administered as a single injection, which makes it convenient compared to other hyaluronic acid treatments that may require multiple injections.

Monovisc and Synvisc both provide effective pain relief for knee osteoarthritis, but they differ in their composition and administration. Monovisc is a single injection of high molecular weight hyaluronic acid, whereas Synvisc can be administered as either three weekly injections or a single large dose (Synvisc-One). The choice between them depends on patient preference and response to treatment.